fashion -WSS

fashion

author：leisure time 2025-09-04 04:25:25 - browse：9479

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Using force crossed my mind when examining a defiant young patient

focus

WSS

'Vaccine

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Medicare isn't yet testing food as medicine

Laying a path for careers in science

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

focus

fashion

focus

Jerome Adams on the need for new antivirals for Covid

'Vaccine

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Anesthesiologist group: stop taking Ozempic before surgery

Roche to buy Carmot Therapeutics, developer of obesity drugs

Trump demands the U.S. pay no more for drugs than other countries … again

Redefining sustainability for the pharmaceutical industry

Jerome Adams on the need for new antivirals for Covid

Medicare isn't yet testing food as medicine

hotspot

STAT letters to the editor on burnt

CMS should re

Redefining sustainability for the pharmaceutical industry

Medicare Advantage isn’t working — for anyone

Children’s Hospital revives plan for pedestrian bridge

Pfizer plans to depart BIO

knowledge

focus

entertainment

Wikipedia